{"abstract":"The National Institute of Drug Abuse, an institute of the National Institutes of Health, Department of Health and Human Services is contemplating the modification of grant of an Exclusive Patent License to EncepHeal Therapeutics, Inc., located in Winston-Salem, North Carolina, to practice the inventions embodied in the patent applications listed in the Supplementary Information section of this notice.","action":"Notice.","agencies":[{"raw_name":"DEPARTMENT OF HEALTH AND HUMAN SERVICES","name":"Health and Human Services Department","id":221,"url":"https://www.federalregister.gov/agencies/health-and-human-services-department","json_url":"https://www.federalregister.gov/api/v1/agencies/221","parent_id":null,"slug":"health-and-human-services-department"},{"raw_name":"National Institutes of Health","name":"National Institutes of Health","id":353,"url":"https://www.federalregister.gov/agencies/national-institutes-of-health","json_url":"https://www.federalregister.gov/api/v1/agencies/353","parent_id":221,"slug":"national-institutes-of-health"}],"body_html_url":"https://www.federalregister.gov/documents/full_text/html/2017/10/02/2017-21048.html","cfr_references":[],"citation":"82 FR 45865","comment_url":null,"comments_close_on":"2017-10-17","correction_of":null,"corrections":[],"dates":"Only written comments and/or applications for a license which are received by the National Institute on Drug Abuse's Technology Transfer Office on or before October 17, 2017 will be considered.","disposition_notes":null,"docket_ids":[],"dockets":[],"document_number":"2017-21048","effective_on":null,"end_page":45866,"executive_order_notes":null,"executive_order_number":null,"full_text_xml_url":"https://www.federalregister.gov/documents/full_text/xml/2017/10/02/2017-21048.xml","html_url":"https://www.federalregister.gov/documents/2017/10/02/2017-21048/prospective-modification-of-exclusive-patent-license-potent-and-selective-analogues-of-monamine","images":{},"images_metadata":{},"json_url":"https://www.federalregister.gov/api/v1/documents/2017-21048?publication_date=2017-10-02","mods_url":"https://www.govinfo.gov/metadata/granule/FR-2017-10-02/2017-21048/mods.xml","not_received_for_publication":null,"page_length":2,"page_views":{"count":96,"last_updated":"2026-06-25 10:15:04 -0400"},"pdf_url":"https://www.govinfo.gov/content/pkg/FR-2017-10-02/pdf/2017-21048.pdf","presidential_document_number":null,"proclamation_number":null,"public_inspection_pdf_url":"https://public-inspection.federalregister.gov/2017-21048.pdf?1506689175","publication_date":"2017-10-02","raw_text_url":"https://www.federalregister.gov/documents/full_text/text/2017/10/02/2017-21048.txt","regulation_id_number_info":{},"regulation_id_numbers":[],"regulations_dot_gov_info":{"checked_regulationsdotgov_at":"2023-02-28T20:21:30Z"},"regulations_dot_gov_url":null,"significant":null,"signing_date":null,"start_page":45865,"subtype":null,"title":"Prospective Modification of Exclusive Patent License Potent and Selective Analogues of: Monamine Transporters; Methods of Making; and Uses Thereof","toc_doc":"Monamine Transporters; Methods of Making; and Uses Thereof","toc_subject":"Exclusive Patent Licenses:","topics":[],"type":"Notice","volume":82}